Diapositive 1

1
MEDICAL SCIENTIFIC INFORMATION
2
Key Information
Company Name MEDICAL SCIENTIFIC
INFORMATIONActivity Promotion and medical
informationDate of creation September
1999Start of activity January
2000Chairman Dr. BOUJBEL LassadGeneral
Manager Dr. CHAIEB Sami Legal Form
Corporation Auditors ZOUIEDI Ali Staff
size 61
3
Scope and activities
MSI is the marketing and commercial arm of MEDIS.
It is in charge of the following activities -
Registration of new products- Promotion and
scientific information- Conception of promotion
materials- Organization of marketing visits and
scientific events (seminars, etc..)-
Coordination and follow-up on sales with PCT and
wholesale pharmacists
4
Marketing Strategy for MEDIS

• Geographic coverage The whole Tunisian
  territory - Promotion team 46 medical
  representatives 5 commercial
  representatives- Promotion materials
  brochures of products
  Visual aid
  Posters
  Stands
  Medical samples
  
  Scientific documentation (Clinical studies)
  Gifts, etc
  

5
Planning of Medical Promotion

• Scientific events - Seminars - EPU -
  Scientific debates - Clinical studies
  conducted with opinion leaders- Leisure
  activities - Dinner invitations for doctors
  - Hotel stays offered to doctors - Paid
  travel and stay expenses of doctors attending
  international seminars - Sea cruises -
  Other

6
Planning of Medical Promotion (2)
46 medical representatives covering the Tunisian
territory
22 covering the Great Tunis area and the
Northern region
1 Supervisor
11 covering Sousse Center region
1 Supervisor
11 covering Sfax Southern region
5 Commercial representatives covering the
Tunisian territory
7
MSI s Portfolio
8
(No Transcript)
9
PRESENTATION
10
Market Potential
Organ Transplantion Number
No of Patients under Dialysis 1600 (1992) 3000 (1997) 3928 (2000)- 5300 (2002) 6400 (2005) 120 CENTERS OF DIALYSIS ( 40 public centers and 80 private centers )
No of Living Transplant Patients 85 at 5 years
No of Transplant Centers 08
No of Kidney Transplantation 534 from 1986 67 (2005 )
No of liver Transplantation 07
No of Heart Transplantation 18 from 1991
No of Pancreas Transplantation 0
No of Bone Marrow Transplantation 134
11
Opinion leaders in Tunisia
Name Specific Activity Hospital City
Pr.TAIEB BEN ABDALLAH Pr. HEDI BEN MAIZ Pr .FETHI YOUNSI Nephrology professors HCN TUNIS
Pr HACHICHA Pr CHARFEDDINE Nephrology professors H HEDI CHAKER SFAX
Pr ACHOUR Pr BEN DHIA Pr ELMAY Nephrology professors H FATOUMA BOURGUIBA MONASTIR
Pr. KAMMOUN Pediatric and nephrology professors HCN TUNIS
Pr. HAFSIA Hematology H LA RABTA TUNIS
Pr MANA Nephrology professor H MILITAIRE TUNIS
Pr GEDDICH HEART transplantation (cardiology) H MILITAIRE TUNIS
Pr ABDELADHIM Pr AG . BEN OTHMAN .T Center of BONE MORROW TRANSPLANTATION CENTRE DE GREFFE DE MOELLE TUNIS
Pr KALFALLAH LIVING TRANSPLANTATION H LA MARSA TUNIS
Pr ELMAY Hematology H FATOUMA BOURGUIBA MONASTIR
Pr BELHADJ LIVING TRANSPLANTATION H SAHLOULE SOUSSE
12
Planning of Medical Promotion
3 medical representatives covering the Tunisian
territory, with strategic assistance from Dr.
Boujbel
. Great TUNIS area. BIZERTE. NABEUL
1 Doctor
1 SupervisorDr. CHAIEB Sami
. SOUSSE. MONASTIR. SFAX
1 Doctor
13
Visit cycles
- Number of specialist doctors using ciclosporin
for organ transplantation or other auto-immune
diseases in Tunisia 300 - Our target is about
240 doctors selected on the basis of their work
potential - Visit cycle 4 weeks - Average
visit rate 30 doctors / week / medical
representative
Quarterly
progress meetings
14
Promotion materials
- A stand of IVAX CR to display when we participate in seminars - A number of CONSUPREN posters - Presents for Professors , - Participation in the yearly national symposium of organ transplantation - Pay the travel and stay expenses of Professors attending international seminars ( opinion leaders), - Documentation about Equoral, - Up-to-date information about Ciclosporine - Clinical studies about all organ transplantations
15
consupren market trends during 00/01/02/03
CONSUPREN MARKET TRENDS
16
Market of EQUORAL 04/05/06/07
17
Products registered - Hepavax-gene (B
hepatitis vaccine) 10 and 20 mcg- Tenders
won 2000 2001 2002 - 2003 2004- 2005-
2006-2007-EPAXAL( A hepatitis vaccine)
18
Market of hepavax-gene
19
Products registred - Sero-tet 250 (anti-tetanic
Immunoglobuline) Tenders won 2000 2001
2002 -2006( 900 000 USD)- Albumin 50 ml
Paramedical HIV diagnostic kit, C Hepatitis , B
Hepatitis
20
Products registered - Hemax (epoitine)
1, 2, 4, 9 MUI Tender winner 2006( 702 000
USD)-2OO7 (558 000 USD) Products being
registered - Bioferon (interferon) 3, 5,
10, MUI - Neutromax (filgrastim) 30 and 48
- HHT 4 UI (growth hormone)
21
(No Transcript)
22
EV OF HEMAX
23
Products being registered (ONCOLOGY)-
Cytocarb (carboplatin) 150 and 450- Paclitax
(paclitaxele) 30 and 100 - Triomune 30 and
40- Lamivir 40 and 160
24
Thank you
Managing Director Dr. Sami CHAIEB